[ad_1] Introduction The prevalence of asthma and allergic rhinitis in adults ranges between 4–9%1–4 and 20–30%, respectively.2,3 Asthma and allergic rhinitis significantly impact public health since they are common diseases closely associated with decreased quality of life1,2 and impaired sleep.3,4 Both disorders are often associated with IgE sensitization and type-2 inflammation.5 Although asthma and allergic rhinitis are chronic diseases, some patients experience periods of remission. Clinical remission of asthma occurred in 20–43% of patients followed during 10–30 years,6–9 while remission of allergic rhinitis has occurred in up […]